Zenicor Medical Systems AB logo

Zenicor Medical Systems AB (ZENI)

Market Closed
10 Aug, 15:25
XSTO XSTO
kr
0. 96
-0.02
-2.0305%
kr
19.1M Market Cap
- P/E Ratio
- Div Yield
12,700 Volume
- Eps
kr 0.98
Previous Close
Add Transaction
Day Range
0.96 1
Year Range
0 0
Want to track ZENI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ZENI closed today lower at kr0.96, a decrease of -2.0305% from yesterday's close, completing a monthly increase of 0% or kr0.96. Over the past 12 months, ZENI stock gained 0%.
ZENI is not paying dividends to its shareholders.
The last earnings report, released on Nov 28, 2025, missed the consensus estimates by -0.0334%. On average, the company has fell short of earnings expectations by -0.0298%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

ZENI Chart

People also search for

OncoZenge AB
kr 5.75
-7.4074%
FRISQ Holding AB
kr 0.7
+6.383%
ScandiDos AB
kr 0.92
+2.809%
GPX Medical AB
kr 2.13
-0.9302%
Redsense Medical AB
kr 4
+0.2506%

Zenicor Medical Systems AB (ZENI) FAQ

What is the stock price today?

The current price is kr0.96.

On which exchange is it traded?

Zenicor Medical Systems AB is listed on XSTO.

What is its stock symbol?

The ticker symbol is ZENI.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 19.1M.

Has Zenicor Medical Systems AB ever had a stock split?

No, there has never been a stock split.

Zenicor Medical Systems AB Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Mats Palerius CEO
XSTO Exchange
- ISIN
SE Country
19 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Zenicor Medical Systems AB (publ) is a prominent medical technology entity focusing on the development of innovative products and solutions aimed at the diagnosis of arrhythmias and the prevention of stroke. Established in 2003 with its headquarters in Stockholm, Sweden, the company gears its efforts towards addressing cardiovascular conditions by leveraging cutting-edge technology. It caters to a wide array of healthcare sectors including cardiology, stroke prevention, medical, pediatrics, clinical physiology, and private clinics across multiple regions such as the Nordics, Germany, Switzerland, Austria, Cyprus, and Great Britain. Through its commitment to excellence and innovation, Zenicor has positioned itself as a leader in the medical technology landscape, improving patient care and outcomes in the realm of heart health and stroke prevention.

Products and Services

Zenicor-ECG

This revolutionary system stands as the cornerstone of Zenicor’s product lineup, addressing the critical need for efficient detection and diagnosis of atrial fibrillation and other arrhythmias. Zenicor-ECG distinguishes itself by enabling patients to record ECG data over extended periods comfortably. These recordings are then effortlessly transmitted to a central ECG database, where healthcare providers can access and analyze the data conveniently through the Internet. This system empowers clinicians with timely and accurate information, facilitating informed decision-making and enhancing patient care in the process. Catered mainly towards cardiology and stroke prevention sectors, Zenicor-ECG epitomizes the integration of technology and healthcare, driving forward the mission of early diagnosis and management of arrhythmias.

Contact Information

Address: SaltmAetargatan 8, Stockholm, Sweden, 113 59
Phone: 46 84 42 68 60